PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,000 | -9.1% | 1,890 | +11.6% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | -66.7% | 1,694 | -0.6% | 0.00% | -86.7% |
| Q1 2019 | $66,000 | +106.2% | 1,705 | +8.6% | 0.02% | +87.5% |
| Q4 2018 | $32,000 | -51.5% | 1,570 | +8.3% | 0.01% | -38.5% |
| Q3 2018 | $66,000 | -16.5% | 1,450 | +8.6% | 0.01% | -18.8% |
| Q2 2018 | $79,000 | -86.9% | 1,335 | -47.5% | 0.02% | -68.0% |
| Q1 2015 | $601,000 | +67.9% | 2,544 | +34.7% | 0.05% | +66.7% |
| Q4 2014 | $358,000 | -12.5% | 1,888 | +10.0% | 0.03% | -9.1% |
| Q3 2014 | $409,000 | +101.5% | 1,717 | -44.3% | 0.03% | +106.2% |
| Q2 2014 | $203,000 | -73.8% | 3,082 | -58.5% | 0.02% | -71.4% |
| Q1 2014 | $774,000 | +46.6% | 7,427 | +45.6% | 0.06% | +36.6% |
| Q4 2013 | $528,000 | – | 5,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |